PASO huge news! Reverse Merger with CLX HealthCare Partners and JV Partners Sirius IQ, backed by UST Global $3,2B in Rev
CLX/UST-Global/SiriusIQ Merger Events Timeline and Flow
2016 to Latest Filings: Investor direct stock purchases to fund the business, rather than toxic debt - many of these investors came back to buy more shares repeatedly over this time (7 pages in latest filing shows these direct investments... of approx. 750M shares outstanding per May 29 LOI disclosure, approx. 603M are restricted. That is, 87% of the O/S is held by insiders and direct investors of restricted stock); the float is less than 150M shares.)
https://backend.otcmarkets.com/otcapi/company...68/content
Oct 24, 2019 (PR): Announced preparing to implement significant management changes, adding members with healthcare and financial expertise.
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=244212
Especially important, this statement from Joseph Gonzolez projects the major corporate developments and unveiling of the merger plans forthcoming:
Quote:
Joseph Gonzalez, representing the Board of Directors, stated, “We have been coordinating with our strategic partner and advisor in planning for several significant material developments on the very near-term horizon which call for us immediately strengthening our management team. Our focus as a Company continues to be driven by coordinating excellent healthcare and growing our already profitable business. In preparing to implement our next sequence of material developments the team has determined the need to strengthen the management hierarchy with executives who maintain backgrounds in finance and healthcare in order to propel through the next strategic objectives ahead.”
Mr. Gonzalez further explained, “We are very excited to begin revealing changes in the management team as we prepare delivering significant tangible results that will greatly enhance our already net profitable shareholder value. We are anticipating additional announcements in the coming days and weeks detailing the changes and transformation the firm is undertaking that will accurately reflect several bold new initiatives designed to greatly enhance our shareholder value moving forward.”
Oct 31 & Nov 4, 2019: High powered industry specialists added to Board of Advisors, Jarvis Shockey, Jon McBride and Brian McCalley (see later records of direct and open market stock purchases by advisors)
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=244885
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=245134
Nov 7, 2019 (tweet): Announcement of Reg A cancellation plan (no need to dilute for funds per merger plan yet to be unveiled)
https://twitter.com/PAShealth/status/1192475031047155713
Dec 16, 2020 (tweet): “All Preferred Series A shares have been returned to the Corporate Treasury. The BoD of the Company has signed a resolution canceling those shares. NV SOS is in the process of being updated.” (clean SS, there are now ZERO preferred shares issued/outstanding)
https://twitter.com/PAShealth/status/1206575006920126464
Jan 3, 2020 (tweet): Management can barely withhold its excitement for the coming material events:
https://twitter.com/PAShealth/status/1213203291640942592
Quote:
Happy New Year Shareholders! As a reminder we are focused on next steps and finalization of material events and the related transition of the Company. We will be posting material event disclosures and expect to provide a full update in the form of a Press Release soon!
Jan 16, 2020 (tweet): Announced plans for merger; the major upcoming milestones will include: 1) LOI for shareholder review, 2) closing (after due diligence period, as always) 3) ‘subsequent “international” announcement’
https://twitter.com/PAShealth/status/1217858342401531908
Feb 13, 2020 (PR): Merger candidate is represented by NY, NY PE firm with $50B under management (the merger opportunity is becoming very real now, with expectations to close soon).
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=253799
Feb 13, 2020 (same PR as above): PASO Annual Report filed, 2019 - $2.26M Gross Profit, $190K Net Profit
- Feb 12, 2020: 2019 Annual Report (referenced in above PR)
https://backend.otcmarkets.com/otcapi/company...21/content
- Feb Mar 3, 2020: Amended/Final 2019 Annual Report
https://backend.otcmarkets.com/otcapi/company...47/content
March 20, 2020 (tweet): “...We are also currently coordinating with our financial advisers to deliver a dividend to our shareholders for your support and patience during this time.” (First mention of a dividend to reward shareholders - which is still pending… will be interesting to see if there is a related announcement before the merger closing; or if we see something afterward)”
https://twitter.com/PAShealth/status/1241062381884706817
Early 2020 (disclosure filings): Insider stock purchases on open market (disclosures also include direct purchases of restricted stock)
Quote:
J. Gonzalez
12.5 Million Open Market
24.5 Direct
https://backend.otcmarkets.com/otcapi/company...01/content
J. Shockey
6 Million Open Market
2.5 Direct
https://backend.otcmarkets.com/otcapi/company...34/content
April 17, 2020 (PR): Announcement concerning imminent major merger news, the LOI timeline: (was delayed due to COVID-19, but very much active and now imminent)
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=259462
Quote:
As we previously shared via our Corporate Twitter account, The Covid-19 Pandemic had a direct impact on the timeline of the negotiations and pending transaction with the Private Equity represented Merger Candidate... We are pleased to announce the process has been restarted with a target date to have a Letter of Intent (LOI) secured on or before May 29th…
April 17, 2020 (same PR as above): With the transaction process being reinitiated we are pleased to announce that the previously announced dividend will be finalized in the coming days. We expect to have a formal announcement regarding calculations and shareholder minimums to participate next week. (doubled down on plan for a dividend to reward shareholders, but this was prior to an NDA between the parties and any related quiet period restrictions… still thinking we MAY not see this until AFTER the merger, but possible news forthcoming)
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=259462
Apr 21, 2020 (disclosure filing): NDA disclosure between the merger parties
https://backend.otcmarkets.com/otcapi/company...43/content
May 29, 2020: (disclosure filing): Merger LOI filed - $3.2B UST Global and Sirius IQ JV to reverse merge into PASO, “...The Closing shall be on July 15, 2020 or sooner, unless the parties hereto agree to another time.” (Due diligence period prior to closing, after which the parties will sign Definitive Agreement)
The AWESOMENESS Link:
https://backend.otcmarkets.com/otcapi/company...95/content
ADDITIONAL DD LINKS & INFO
CLX HealthCare Partners and JV Partners Sirius IQ and UST Global
SiriusIQ: SiriusIQ is focused on next-gen Master Orchestration and Automation of data to streamline business processes, conversations, analytics and more. SiriusIQ based solutions are faster, better and smarter and integrate Native Cloud Services, Human-Assisted AI, Continuous Integration Continuous Delivery of Data and Subject Matter Expert Collaboration. A graduate
of Microsoft BizSpark Plus incubator, SiriusIQ has been named a 'Cool Vendor' by Gartner and a 'Hot Vendor' by HfS Research.
For more information, visit us at https://www.siriusiq.com/
UST Global: is a multinational provider of Digital technology and transformation, IT services and solutions, headquartered in Aliso Viejo, California, United States. The Company has 23,000 employees and offices in over 25 countries including USA, India, Mexico, UK, Malaysia, Philippines, Singapore, Spain and Poland. UST Global has oriented its services around the following major platforms to offer our services in a Business Platform-as-a-Service (BPaaS) model while continuing to support enterprise-class customers with more traditional IT and BPO services.
For more information, visit us at https://www.ust-global.com/
Clients of UST Global include Fortune 500 companies in banking and financial services, insurance, healthcare, retail, manufacturing, shipping, technology, semiconductor and telecom.
$3.2 Billion .....23,000 employees in over 25 countries !!
UST Global & SiriusIQ will take PASO to the Nasdaq within the first year.
Now we know why the $50B PE firm was involved this entire time.
PASO Share Structure (soon to be CLXH??? Soon to be trading QB… and then Nasdaq soon???)
Quote:
NO PREFERRED SHARES
Authorized Shares
750,000,000
05/13/2020
Outstanding Shares
695,792,454 (approx. 750,000,000 per LOI filed on 5/29/2020… assume ~50M direct purchases or executive deals for new/merged entity)
05/13/2020
Float
146,425,869
05/01/2020
https://twitter.com/PAShealth
https://www.otcmarkets.com/stock/PASO/security
They Also Have Little Debt, No Convertible Notes!
CLX/UST-Global/SiriusIQ Merger Events Timeline and Flow
2016 to Latest Filings: Investor direct stock purchases to fund the business, rather than toxic debt - many of these investors came back to buy more shares repeatedly over this time (7 pages in latest filing shows these direct investments... of approx. 750M shares outstanding per May 29 LOI disclosure, approx. 603M are restricted. That is, 87% of the O/S is held by insiders and direct investors of restricted stock); the float is less than 150M shares.)
https://backend.otcmarkets.com/otcapi/company...68/content
Oct 24, 2019 (PR): Announced preparing to implement significant management changes, adding members with healthcare and financial expertise.
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=244212
Especially important, this statement from Joseph Gonzolez projects the major corporate developments and unveiling of the merger plans forthcoming:
Quote:
Joseph Gonzalez, representing the Board of Directors, stated, “We have been coordinating with our strategic partner and advisor in planning for several significant material developments on the very near-term horizon which call for us immediately strengthening our management team. Our focus as a Company continues to be driven by coordinating excellent healthcare and growing our already profitable business. In preparing to implement our next sequence of material developments the team has determined the need to strengthen the management hierarchy with executives who maintain backgrounds in finance and healthcare in order to propel through the next strategic objectives ahead.”
Mr. Gonzalez further explained, “We are very excited to begin revealing changes in the management team as we prepare delivering significant tangible results that will greatly enhance our already net profitable shareholder value. We are anticipating additional announcements in the coming days and weeks detailing the changes and transformation the firm is undertaking that will accurately reflect several bold new initiatives designed to greatly enhance our shareholder value moving forward.”
Oct 31 & Nov 4, 2019: High powered industry specialists added to Board of Advisors, Jarvis Shockey, Jon McBride and Brian McCalley (see later records of direct and open market stock purchases by advisors)
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=244885
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=245134
Nov 7, 2019 (tweet): Announcement of Reg A cancellation plan (no need to dilute for funds per merger plan yet to be unveiled)
https://twitter.com/PAShealth/status/1192475031047155713
Dec 16, 2020 (tweet): “All Preferred Series A shares have been returned to the Corporate Treasury. The BoD of the Company has signed a resolution canceling those shares. NV SOS is in the process of being updated.” (clean SS, there are now ZERO preferred shares issued/outstanding)
https://twitter.com/PAShealth/status/1206575006920126464
Jan 3, 2020 (tweet): Management can barely withhold its excitement for the coming material events:
https://twitter.com/PAShealth/status/1213203291640942592
Quote:
Happy New Year Shareholders! As a reminder we are focused on next steps and finalization of material events and the related transition of the Company. We will be posting material event disclosures and expect to provide a full update in the form of a Press Release soon!
Jan 16, 2020 (tweet): Announced plans for merger; the major upcoming milestones will include: 1) LOI for shareholder review, 2) closing (after due diligence period, as always) 3) ‘subsequent “international” announcement’
https://twitter.com/PAShealth/status/1217858342401531908
Feb 13, 2020 (PR): Merger candidate is represented by NY, NY PE firm with $50B under management (the merger opportunity is becoming very real now, with expectations to close soon).
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=253799
Feb 13, 2020 (same PR as above): PASO Annual Report filed, 2019 - $2.26M Gross Profit, $190K Net Profit
- Feb 12, 2020: 2019 Annual Report (referenced in above PR)
https://backend.otcmarkets.com/otcapi/company...21/content
- Feb Mar 3, 2020: Amended/Final 2019 Annual Report
https://backend.otcmarkets.com/otcapi/company...47/content
March 20, 2020 (tweet): “...We are also currently coordinating with our financial advisers to deliver a dividend to our shareholders for your support and patience during this time.” (First mention of a dividend to reward shareholders - which is still pending… will be interesting to see if there is a related announcement before the merger closing; or if we see something afterward)”
https://twitter.com/PAShealth/status/1241062381884706817
Early 2020 (disclosure filings): Insider stock purchases on open market (disclosures also include direct purchases of restricted stock)
Quote:
J. Gonzalez
12.5 Million Open Market
24.5 Direct
https://backend.otcmarkets.com/otcapi/company...01/content
J. Shockey
6 Million Open Market
2.5 Direct
https://backend.otcmarkets.com/otcapi/company...34/content
April 17, 2020 (PR): Announcement concerning imminent major merger news, the LOI timeline: (was delayed due to COVID-19, but very much active and now imminent)
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=259462
Quote:
As we previously shared via our Corporate Twitter account, The Covid-19 Pandemic had a direct impact on the timeline of the negotiations and pending transaction with the Private Equity represented Merger Candidate... We are pleased to announce the process has been restarted with a target date to have a Letter of Intent (LOI) secured on or before May 29th…
April 17, 2020 (same PR as above): With the transaction process being reinitiated we are pleased to announce that the previously announced dividend will be finalized in the coming days. We expect to have a formal announcement regarding calculations and shareholder minimums to participate next week. (doubled down on plan for a dividend to reward shareholders, but this was prior to an NDA between the parties and any related quiet period restrictions… still thinking we MAY not see this until AFTER the merger, but possible news forthcoming)
https://www.otcmarkets.com/stock/PASO/news/Pa...?id=259462
Apr 21, 2020 (disclosure filing): NDA disclosure between the merger parties
https://backend.otcmarkets.com/otcapi/company...43/content
May 29, 2020: (disclosure filing): Merger LOI filed - $3.2B UST Global and Sirius IQ JV to reverse merge into PASO, “...The Closing shall be on July 15, 2020 or sooner, unless the parties hereto agree to another time.” (Due diligence period prior to closing, after which the parties will sign Definitive Agreement)
The AWESOMENESS Link:
https://backend.otcmarkets.com/otcapi/company...95/content
ADDITIONAL DD LINKS & INFO
CLX HealthCare Partners and JV Partners Sirius IQ and UST Global
SiriusIQ: SiriusIQ is focused on next-gen Master Orchestration and Automation of data to streamline business processes, conversations, analytics and more. SiriusIQ based solutions are faster, better and smarter and integrate Native Cloud Services, Human-Assisted AI, Continuous Integration Continuous Delivery of Data and Subject Matter Expert Collaboration. A graduate
of Microsoft BizSpark Plus incubator, SiriusIQ has been named a 'Cool Vendor' by Gartner and a 'Hot Vendor' by HfS Research.
For more information, visit us at https://www.siriusiq.com/
UST Global: is a multinational provider of Digital technology and transformation, IT services and solutions, headquartered in Aliso Viejo, California, United States. The Company has 23,000 employees and offices in over 25 countries including USA, India, Mexico, UK, Malaysia, Philippines, Singapore, Spain and Poland. UST Global has oriented its services around the following major platforms to offer our services in a Business Platform-as-a-Service (BPaaS) model while continuing to support enterprise-class customers with more traditional IT and BPO services.
For more information, visit us at https://www.ust-global.com/
Clients of UST Global include Fortune 500 companies in banking and financial services, insurance, healthcare, retail, manufacturing, shipping, technology, semiconductor and telecom.
$3.2 Billion .....23,000 employees in over 25 countries !!
UST Global & SiriusIQ will take PASO to the Nasdaq within the first year.
Now we know why the $50B PE firm was involved this entire time.
PASO Share Structure (soon to be CLXH??? Soon to be trading QB… and then Nasdaq soon???)
Quote:
NO PREFERRED SHARES
Authorized Shares
750,000,000
05/13/2020
Outstanding Shares
695,792,454 (approx. 750,000,000 per LOI filed on 5/29/2020… assume ~50M direct purchases or executive deals for new/merged entity)
05/13/2020
Float
146,425,869
05/01/2020
https://twitter.com/PAShealth
https://www.otcmarkets.com/stock/PASO/security
They Also Have Little Debt, No Convertible Notes!
